Matinas BioPharma Holdings (MTNB) Change in Acquisitions & Divestments (2020 - 2024)

Matinas BioPharma Holdings (MTNB) has reported Change in Acquisitions & Divestments for 5 consecutive years, with $500000.0 the latest figure, recorded in Q4 2024.

• In Q4 2024, Change in Acquisitions & Divestments fell 83.11% year-over-year to $500000.0; the TTM figure through Dec 2024 stood at $17.6 million (up 31.09% YoY), while the FY2024 annual figure was $17.6 million, up 31.09% from the prior year.
• Change in Acquisitions & Divestments fell to $500000.0 in Q4 2024 per MTNB's latest filing, from $10.1 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $14.4 million in Q2 2020 and bottomed at $500000.0 in Q4 2024.
• Historically, Change in Acquisitions & Divestments has averaged $6.2 million across 5 years, with a median of $6.0 million in 2022.
• On a YoY basis, Change in Acquisitions & Divestments climbed as much as 822.27% in 2024 and fell as far as 83.11% in 2024.
• Matinas BioPharma Holdings' Change in Acquisitions & Divestments stood at $7.0 million in 2020, then slipped by 21.37% to $5.5 million in 2021, then increased by 9.09% to $6.0 million in 2022, then sank by 50.67% to $3.0 million in 2023, then tumbled by 83.11% to $500000.0 in 2024.
• Business Quant data shows MTNB's Change in Acquisitions & Divestments at $500000.0 in Q4 2024, $10.1 million in Q3 2024, and $5.0 million in Q2 2024.